Happily, not much sun exposure is required for many people to meet their vitamin D needs. Ten minutes of sun exposure at a UV ...

Newronika announced today that it closed a €13.6 million ($14.1 million) Series B round to support its deep brain stimulation ...

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an ...

Hip fractures in older adults can lead to serious complications, disability and even death. Traditionally, orthopaedic ...

The partnership between the US military body and the non-profit Global Coalition for Adaptive Research will examine three ...

The partnership will integrate PhaseV's adaptive clinical trial technology with Alimentiv's comprehensive GI CRO services.

Agenus has robust end-to-end development capabilities, across commercial and clinical cGMP manufacturing facilities, research and discovery ... boost both innate and adaptive anti-tumor immune ...